Stockreport

Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M [Yahoo! Finance]

Indivior PLC - Ordinary Shares  (INDV) 
PDF Indivior PLC (NASDAQ:INDV) is a pharmaceutical company specializing in treatments for opioid use disorder (OUD), with its core products SUBLOCADE, a once-monthly bupren [Read more]